OA
Operose Advisors’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3K | Hold |
183
| – | – | ﹤0.01% | 316 |
|
|
2025
Q1 | $13.3K | Hold |
183
| – | – | ﹤0.01% | 303 |
|
|
2024
Q4 | $13.5K | Sell |
183
-452
| -71% | -$33.5K | ﹤0.01% | 284 |
|
|
2024
Q3 | $41.9K | Hold |
635
| – | – | 0.01% | 290 |
|
|
2024
Q2 | $58.7K | Hold |
635
| – | – | 0.02% | 229 |
|
|
2024
Q1 | $60.7K | Sell |
635
-451
| -42% | -$43.1K | 0.02% | 233 |
|
|
2023
Q4 | $82.8K | Buy |
1,086
+451
| +71% | +$34.4K | 0.03% | 173 |
|
|
2023
Q3 | $44K | Buy |
635
+452
| +247% | +$31.3K | 0.02% | 332 |
|
|
2023
Q2 | $17.3K | Hold |
183
| – | – | 0.01% | 248 |
|
|
2023
Q1 | $15.1K | Hold |
183
| – | – | 0.01% | 245 |
|
|
2022
Q4 | $13.7K | Hold |
183
| – | – | 0.01% | 253 |
|
|
2022
Q3 | $15K | Hold |
183
| – | – | 0.01% | 237 |
|
|
2022
Q2 | $17K | Hold |
183
| – | – | 0.01% | 208 |
|
|
2022
Q1 | $22K | Hold |
183
| – | – | 0.02% | 205 |
|
|
2021
Q4 | $24K | Buy |
+183
| New | +$24K | 0.02% | 191 |
|